About Ensoma
Develops a genomic medicine platform for in vivo engineering of hematopoietic stem cells.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Boston, United States
Team Size
51-100
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
ensoma.com
Domain Registered Date
May 11, 2003
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $50,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Series-B+ announced
fundraisingfox.com
- Milestone
X account created (@EnsomaBio)
356 followers
- Milestone
Website domain registered
ensoma.com
Investors & Backers
Bill & Melinda Gates Foundation
Bioluminescence Ventures
Cormorant Asset Management
Delos Capital
F-Prime Capital
Gilead Sciences
Kite Pharma
Mirae Asset Financial Group
RTW Investments
Solasta Ventures
SymBiosis
Viking Global Investors
Funding History
Series-B+
· May 16, 2023
$50,000,000 fundraisingfox.com
Series-B+
· Jan 10, 2023
Undisclosed fundraisingfox.com
Founders & Leadership
Andre Lieber
Founder
Work email & phone locked
Unlock →
Emile F. Nuwaysir
CEO
Work email & phone locked
Unlock →
Hans Peter Kiem
Founder
Work email & phone locked
Unlock →
Jon Garen
Chief Corporate Development and Business Officer
Work email & phone locked
Unlock →
Min Wang
Chief Operating Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026